40 pharma companies interested in producing anti COVID-19 drug, DRDO tells Madras High Court
The Hindu
The submission was made in response to a PIL petition complaining that DRDO had given a licence to Dr. Reddy’s Laboratories in Hyderabad alone for manufacturing the oral powder
The Defence Research and Development Organisation (DRDO) on Friday told the Madras High Court that it had invited Expression of Interest to produce its 2-deoxy-D-glucose (2-DG), an adjunct drug to treat COVID-19 patients, and so far 40 pharmaceutical companies had shown interest in manufacturing it. Appearing before the second Division Bench of Justices N. Kirubakaran and T.V. Thamilselvi, Additional Solicitor General R. Sankaranarayanan said the DRDO was highly interested in ensuring that the drug, developed by its Institute of Nuclear Medicine and Allied Sciences, could be manufactured in as much quantity as possible within the shortest possible time.More Related News
Budding businesswomen engaged in producing ecologically sustainable products got an opportunity to improve their visibility, thanks to a programme launched by Tiruchi Regional Engineering College – Science and Technology Entrepreneurs (TREC-STEP) in collaboration with online platform Maheela Power recently